9,671 results found

The European Commission's draft new EU Merger Guidelines and the UK's evolving approach signal a shift in how mergers are analyzed amid changing geopolitical dynamics. Partner James K. Hunsberger joins Brunswick's Stuart Hudson and Matthew Hall to explore what these regulatory changes mean for merger control, examining potential EU/UK convergence or divergence and the growing risk of politicization in competition reviews.

McDermott's Antitrust M&A Snapshot is a resource for in-house counsel and others who deal with antitrust M&A issues but are not faced with these issues on a daily basis

The proposed Paramount-Warner Bros. transaction reveals a fundamental shift in global merger review dynamics, where U.K. regulators now wield unprecedented influence over American media deals. This analysis explores how the Competition and Markets Authority's expanding jurisdictional reach and distinct antitrust standards create new strategic challenges for multinational companies.

The FTC's record-setting $12 million settlement with Edwards Lifesciences and Genesis MedTech raises critical questions about deal structuring and Hart-Scott-Rodino Act compliance. When does strategic transaction design cross the line into intentional avoidance of premerger notification requirements? Leading antitrust practitioners examine the implications of this landmark enforcement action for deal teams navigating transactions near HSR thresholds.

On Sept. 25, 2013, the Federal Trade Commission and the Department of Justice issued an updated joint model waiver of confidentiality for individuals and companies to use in merger and non-merger matters.

Promoting competition among health care providers remains a top priority for the Federal Trade Commission and it is expected that the FTC will continue to challenge mergers in the health care industry.

David Reichenberg contributed an article to Forbes discussing why certain companies have chosen to go public via SPAC

David Reichenberg was quoted in a Global Competition Review article that discusses how the Federal Trade Commission and Department of Justice have said they intend to jointly review their merger

Healthcare companies face intensifying antitrust scrutiny as regulators adapt their enforcement strategies to address evolving industry dynamics. What are the three critical risk areas that healthcare organizations must monitor in 2026, and how are changing enforcement priorities reshaping regulatory oversight across the sector?

Antitrust law today is the subject of intense public and political focus. Scrutiny of M&A activity in particular continues to be an area of priority for federal antitrust enforcers.

"Cannabis mergers and acquisitions are making a comeback after a turbulent few years for the industry. Over the past several months, multibillion-dollar deals like Tilray's merger with Aphria and Trulieve's

In our most recent Law360 column, we tackled a series of basic investment premises and common misconceptions about investing in the ambulatory surgery center (ASC) industry.

Fox Rothschild LLP was featured in the Philly.com article, "After 110 Years, Family Sells West Chester Fan-Maker to Private-Equity Firms."

Jordan Altman discusses the necessary steps—from developing source code to active filings—in protecting a FinTech company's intellectual property rights during an M&A transaction...

Andrew Lucano, Richard Lutkus, Tushar Vaidya authored a December 22 article in the ACG Chicago Journal, "Cybersecurity Threats May Be Lurking In Your Next M&A Deal."

Andrew Sherman was quoted in "Musk's 'out of cash' dilemma many business founders love to share," an April 27 story from CNBC.com on business owners' difficult decision to sell a piece or...

Michael A. Hyett, Lloyd P. Eisen, Robert P. Lang, Peter S. Myers and Sean R. Kenney were featured in The Legal Intelligencer article, "As Merger Fever Continues, Phila. Market Is Hot."